Zhengye Biotechnology Holding (ZYBT) Non-Current Assets (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has reported Non-Current Assets for 3 consecutive years, with $42.2 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Non-Current Assets fell 4.06% year-over-year to $42.2 million in Q4 2025; TTM through Dec 2025 was $42.2 million, a 4.06% decrease from a year earlier, with the FY2025 full-year figure at $42.8 million, down 1.13% from the prior year.
• Non-Current Assets was $42.2 million for Q4 2025 at Zhengye Biotechnology Holding, roughly flat from $42.3 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $43.9 million in Q4 2024 and troughed at $42.2 million in Q4 2025.
• A 3-year average of $42.9 million and a median of $42.7 million in 2023 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets increased 1.86% in 2024 and dropped 4.06% in 2025, its largest moves.
• Over 3 years, Non-Current Assets stood at $43.1 million in 2023, then advanced by 1.86% to $43.9 million in 2024, then fell by 4.06% to $42.2 million in 2025.
• The last three Non-Current Assets figures came in at $42.2 million (Q4 2025), $42.3 million (Q2 2025), and $43.9 million (Q4 2024), per Business Quant data.